THAT isn't what i said…i said they have NOT done toxicity tests…they are NOT in FDA trials or even scheduled for it….therefor they are NOWHERE near having a marketable drug nor will they in the near future……imo shareholders better prepare for more dilution….they have money for the toxicity tests and through phase II?….last time i checked it takes Phase III as well.
Market Data 
Markets 
AI
